Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,202 across all filing types
Latest filing 2020-11-12 M&A Activity
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Amalgamation/Merger
M&A Activity Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the National Company Law Tribunal (NCLT) order sanctioning the merger of wholly owned subsidiaries with the company. It references previous communications and provides details about the merger approval and effective date. The document is an official announcement regarding a corporate restructuring event (merger) and does not contain financial statements, audit information, or detailed financial analysis. It is not a full report but an update on a corporate action. Therefore, it fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids.
2020-11-12 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2020-11-09 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges regarding a request received for the issuance of a duplicate share certificate due to loss of the original certificate. It references Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which governs such disclosures. The content is procedural and informational about share certificate replacement, not about financial results, management changes, or other report types. It does not contain financial data or detailed report content. This type of announcement fits best under Regulatory Filings (RNS), as it is a compliance-related disclosure to the stock exchanges that does not fit other specific categories.
2020-11-06 English
Updates
Board/Management Information Classification · 95% confidence The document is an official letter addressed to stock exchanges regarding the reclassification of a shareholder entity from 'Promoter Group' to 'Public Category' as per Regulation 31A of SEBI Listing Regulations. It includes an extract of the minutes of the Board of Directors meeting where the reclassification was approved and the resolution passed. The content focuses on board decisions and shareholder approval processes related to shareholding classification, not on financial results, audit, or other report types. This fits the category of Board/Management Information (MANG), which covers announcements of changes in company board decisions or senior management-related matters. The document is not a full financial report, earnings release, or regulatory filing of another type, but a formal board announcement regarding shareholding classification changes.
2020-10-29 English
Scheme of Arrangement
Capital/Financing Update Classification · 95% confidence The document is an update on the intimation of a Scheme of Amalgamation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details the merger of a wholly-owned subsidiary with the parent company, including regulatory approvals, company details, rationale, and shareholding impact. The document is a formal announcement to stock exchanges about the merger scheme and its update, not the merger agreement itself or a full merger filing. It is a regulatory announcement under SEBI regulations, providing disclosure information as required by listing obligations. The document length is about 6409 characters, which is consistent with a detailed regulatory announcement but not a full merger filing or proxy statement. Therefore, the best fitting category is Capital/Financing Update (CAP), as it relates to corporate restructuring and merger updates disclosed under capital market regulations.
2020-10-29 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 100% confidence The document is a formal letter addressed to stock exchanges announcing the allotment of shares under an Employee Stock Option Plan (ESOP). It specifies the number of shares allotted, the increase in paid-up share capital, and confirms that the new shares rank pari passu with existing shares. There is no detailed financial data or comprehensive report content, only a capital change announcement. The document length is short (1150 characters), and it is clearly an announcement of a share capital change due to ESOP allotment. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA).
2020-10-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.